Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 27, 2024VirusesOpen Access

Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJoana FerreiraMBManuel BichoFSFátima Serejo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ferreira et al. (2024) studied this question.

synapsesocial.com/papers/68e77577b6db6435876ea19bhttps://doi.org/10.3390/v16030371
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1CHANGES IN METABOLIC AND RENAL SYSTEM AFTER HCV CLEARANCE IN CHRONIC VIRAL HEPATITIS PATIENTS TREATED WITH DIRECT-ACTING ANTIVIRALS2024 · 1 citations
  2. 2Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection2022 · 23 citations
  3. 3Metabolic Effects of Direct-Acting Antiviral Therapy in Chronic Hepatitis C: A Focus on Glucose and Lipid Profiles2025
  4. 4Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study2026
  5. 5Prospective Assessment of Serum Lipid Alterations in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals: Insights Six Months Post Sustained Virological Response2024 · 2 citations